Suppr超能文献

常用药物的含糖量、致龋性及牙齿相关问题。

Sugar content, cariogenicity, and dental concerns with commonly used medications.

作者信息

Donaldson Mark, Goodchild Jason H, Epstein Joel B

出版信息

J Am Dent Assoc. 2015 Feb;146(2):129-33. doi: 10.1016/j.adaj.2014.10.009.

Abstract

BACKGROUND AND OVERVIEW

Oral adverse events such as cariogenicity are often overlooked as drug-associated effects because the sugar content of many medications may be negligible compared with the patients' overall dietary intake of sugar. There are, however, several liquid formulations of medications with significantly high sugar content that are commonly used in patients with swallowing difficulties. These medications may be associated with negative oral health sequelae and should be considered part of the oral health care providers' differential diagnosis of oral pathologies.

METHODS

We reviewed the literature regarding the sugar content of oral liquid medications commonly prescribed by oral health care providers, with consideration to their caries potential. Where not available via public sources, pharmaceutical companies were contacted directly for additional information on the sugar (carbohydrate) content of these oral liquid medication formulations.

RESULTS

Over 50 commonly used oral liquid medications prescribed for patients with swallowing difficulties were reviewed and found to contain sugar in varying amounts up to 4 grams per dose (usually 1 teaspoon or 5 milliliters). Patients who are required to take multiple doses per day of these sugar-containing oral liquid medications may be at increased risk for caries and associated oral health consequences.

CONCLUSIONS AND PRACTICAL IMPLICATIONS

Recognition and avoidance of sugar-containing oral liquid medications can help clinicians optimize patient treatment, decreasing the risk for potential drug-induced caries while emphasizing patient safety and improved oral health.

摘要

背景与概述

诸如致龋性等口腔不良事件常被忽视,未被视为与药物相关的效应,因为与患者总体饮食中的糖摄入量相比,许多药物的含糖量可能微不足道。然而,有几种含糖量显著高的液体制剂药物常用于吞咽困难的患者。这些药物可能与不良的口腔健康后果相关,应被视为口腔保健提供者对口腔病变进行鉴别诊断的一部分。

方法

我们查阅了有关口腔保健提供者常用的口服液体制剂含糖量的文献,并考虑了它们的致龋潜力。若无法通过公开来源获取信息,则直接联系制药公司以获取有关这些口服液体制剂含糖(碳水化合物)量的更多信息。

结果

对为吞咽困难患者开具的50多种常用口服液体制剂进行了审查,发现其含糖量各不相同,每剂高达4克(通常为1茶匙或5毫升)。每天需要服用多剂这些含糖口服液体制剂的患者患龋齿及相关口腔健康问题的风险可能会增加。

结论与实际意义

识别并避免使用含糖口服液体制剂有助于临床医生优化患者治疗,降低潜在药物性龋齿的风险,同时强调患者安全并改善口腔健康。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验